John Sutton Welch

24.3k citations
178 papers · 19.6k · 11 hit papers · h-index 43

Impact in

  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Cancer Genomics and Diagnostics

Papers in

John Sutton Welch

172 papers receiving 19.1k citations

John Sutton Welch's Hit Papers

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial 2020 · 258 citations
2580+9+18Years since publication10002.0k3.0k

Peers

John Sutton Welch
Comparison fields: 5 of 159
  • Hematology 7.2k
  • Cancer Research 4.8k
  • Genetics 2.4k
  • Molecular Biology 9.4k
  • Oncology 2.8k
Replace Jonathan D. Licht with:
Jonathan D. Licht United States
Adriana Heguy United States
Carsten Müller‐Tidow Germany
Ramesh A. Shivdasani United States
Joseph R. Testa United States
Christine Chomienne France
Richard M. Lawn United States
Robert John Arceci United States
Iannis Aifantis United States
Julie Teruya‐Feldstein United States
John Sutton Welch relative to Jonathan D. Licht United States Jonathan D. Licht's profile →
Citations per field
00.5×1.5×
Jonathan D. Licht · 1×
Citations per year

Countries citing papers authored by John Sutton Welch

Since Specialization
Citations

This map shows the geographic impact of John Sutton Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sutton Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sutton Welch more than expected).

Fields of papers citing papers by John Sutton Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Sutton Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sutton Welch. The network helps show where John Sutton Welch may publish in the future.

Co-authors

The 25 scholars most cited alongside John Sutton Welch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Sutton Welch Line = papers co-authored together John Sutton Welch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mutational landscape and significance across 12 major cancer types
Hit paper breakdown →
20133530
2
DNMT3A Mutations in Acute Myeloid Leukemia
Hit paper breakdown →
20101657
3
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Hit paper breakdown →
20121645
4
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Hit paper breakdown →
20141511
5
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
Hit paper breakdown →
20121285
6
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Hit paper breakdown →
2000936
7
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Hit paper breakdown →
1999779
8
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Hit paper breakdown →
2014715
9
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Hit paper breakdown →
2016679
10 1998652
11 2003382
12
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
Hit paper breakdown →
2018371
13 2014353
14 2015286
15 1999274
16
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
Hit paper breakdown →
2020258
17 2015240
18 2002205
19 2011199
20 2015186

About John Sutton Welch

John Sutton Welch is a scholar working on Hematology, Obstetrics and Gynecology, Cancer Research, Molecular Biology and Parasitology, having authored 178 papers that have together received 19.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (65 papers), Retinoids in leukemia and cellular processes (25 papers), Cancer Genomics and Diagnostics (19 papers), Multiple Myeloma Research and Treatments (13 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Protein Degradation and Inhibitors (9 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Ovarian cancer diagnosis and treatment (8 papers). The work is most often cited by research in Hematology (7.2k citations), Cancer Research (4.8k citations), Genetics (2.4k citations), Molecular Biology (9.4k citations) and Oncology (2.8k citations). John Sutton Welch has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Mercedes Ricote, Christopher K. Glass, Timothy James Ley, Matthew J. Walter, Christopher A. Miller, Richard K. Wilson, Li Ding, Mingchao Xie, Michael D. McLellan and Michael C. Wendl. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Blood, Haematologica, Transactions of the Royal Society of Tropical Medicine and Hygiene and Obstetrical & Gynecological Survey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact